Juan Francisco Grau-Béjar

A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030)

Juan Francisco Grau-Béjar, Lorena Fariñas-Madrid, Ana Oaknin · International Journal of Gynecological Cancer · 2019 · 78 citations

Usefulness of Alanine and Aspartate Aminotransferases in the Diagnosis of Microlithiasis in Idiopathic Acute Pancreatitis

Juan Francisco Grau-Béjar, Pedro Almela, Luís Aparisi et al. · International Journal of Gastrointestinal Cancer · 1999 · 28 citations

ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation

Carmen García-Durán, Juan Francisco Grau-Béjar, Guillermo Villacampa et al. · International Journal of Gynecological Cancer · 2022 · 24 citations · Full text

Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer

Juan Francisco Grau-Béjar, E. Yaniz Galende, Qinghe Zeng et al. · Journal for ImmunoTherapy of Cancer · 2024 · 20 citations · Full text

Novel Therapies in Gynecologic Cancer

Juan Francisco Grau-Béjar, Ana Oaknin, Casey W. Williamson et al. · American Society of Clinical Oncology Educational Book · 2022 · 19 citations · Full text

Gynecology, Pathology, Gynecology Oncology +16